These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 18198396
1. Phenethyl isothiocyanate suppresses receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis by blocking activation of ERK1/2 and p38 MAPK in RAW264.7 macrophages. Murakami A, Song M, Ohigashi H. Biofactors; 2007; 30(1):1-11. PubMed ID: 18198396 [Abstract] [Full Text] [Related]
2. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J. J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [Abstract] [Full Text] [Related]
3. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation. Wang C, Steer JH, Joyce DA, Yip KH, Zheng MH, Xu J. J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351 [Abstract] [Full Text] [Related]
4. Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway. Huh JE, Lee WI, Kang JW, Nam D, Choi DY, Park DS, Lee SH, Lee JD. J Nat Prod; 2014 Nov 26; 77(11):2423-31. PubMed ID: 25397676 [Abstract] [Full Text] [Related]
11. A pterostilbene derivative suppresses osteoclastogenesis by regulating RANKL-mediated NFκB and MAPK signaling in RAW264.7 cells. Nikhil K, Sharan S, Roy P. Pharmacol Rep; 2015 Dec 26; 67(6):1264-72. PubMed ID: 26481551 [Abstract] [Full Text] [Related]
14. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways. Chen G, Xu Q, Dai M, Liu X. Biochem Biophys Res Commun; 2019 Feb 05; 509(2):329-334. PubMed ID: 30579598 [Abstract] [Full Text] [Related]
15. Inhibition of tumor progression locus 2 protein kinase suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis through down-regulation of the c-Fos and nuclear factor of activated T cells c1 genes. Hirata K, Taki H, Shinoda K, Hounoki H, Miyahara T, Tobe K, Ogawa H, Mori H, Sugiyama E. Biol Pharm Bull; 2010 Feb 05; 33(1):133-7. PubMed ID: 20045951 [Abstract] [Full Text] [Related]
16. Water solution of onion crude powder inhibits RANKL-induced osteoclastogenesis through ERK, p38 and NF-kappaB pathways. Tang CH, Huang TH, Chang CS, Fu WM, Yang RS. Osteoporos Int; 2009 Jan 05; 20(1):93-103. PubMed ID: 18506384 [Abstract] [Full Text] [Related]
17. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity. Ang ES, Pavlos NJ, Chai LY, Qi M, Cheng TS, Steer JH, Joyce DA, Zheng MH, Xu J. J Cell Physiol; 2009 Dec 05; 221(3):642-9. PubMed ID: 19681045 [Abstract] [Full Text] [Related]
20. Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-κB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-κB-induced RAW264.7 cells. Wang X, Zhu Y, Zheng S, Ni C, Zhao L, Liu C, Chen A, Xiao J. Mol Med Rep; 2015 May 05; 11(5):3451-6. PubMed ID: 25592168 [Abstract] [Full Text] [Related] Page: [Next] [New Search]